Hookipa Pharma Funding: $30M Raised, Series B (2023)
Hookipa Pharma is based in Vienna, Austria. It has raised $30M in total funding. Latest round: Series B.
Hookipa Pharma funding overview
Hookipa Pharma is based in Vienna, Austria. Hookipa Pharma has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in June 2023. The round record for Hookipa Pharma runs through 2023; nothing later has been disclosed. Investors on record include Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures, BioMedPartners. 5 distinct backers are named across the disclosed rounds.
Hookipa Pharma has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Hookipa Pharma?
Sofinnova Partners, Forbion Capital Partners, Boehringer Ingelheim Venture Fund, Takeda Ventures, BioMedPartners are named among the investors backing Hookipa Pharma.
What was the latest Hookipa Pharma funding round?
The most recent disclosed round is a Series B, announced in June 2023.
Where is Hookipa Pharma based?
Hookipa Pharma is based in Vienna, Austria.
When did Hookipa Pharma last raise?
The last disclosed Hookipa Pharma round closed in June 2023 at Series B.
Every Hookipa Pharma figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Vienna at a similar stage.
